Structural Heart Devices Market
Structural Heart Devices Market By Product (Heart Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Others), By Procedure (Replacement Procedures, Repair Procedures), By Age Group (Pediatrics, Adults, Geriatrics), By Indication (ASD, VSD, Others), By End User & Region - Global Market Insights 2023-2033
Analysis of Structural Heart Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Structural Heart Devices Market Outlook (2023-2033)
Increasing at an impressive CAGR of 11%, the global structural heart devices market is expected to increase from a valuation of US$ 12.17 billion in 2023 to US$ 36.06 billion by 2033-end.
Structural heart devices are further bifurcated into heart valve devices, surgical heart valves, transcatheter heart valves, and occluders & delivery systems. Worldwide demand for heart valve devices is expected to rise rapidly at a CAGR of 11.5% from 2023 to 2033.
The heart valve makes sure that the blood is flowing correctly and under the proper pressure. The backward flow of blood via a valve as opposed to the usual unidirectional flow is known as valve regurgitation. The need for prosthetic heart valves has increased due to the rising prevalence of cardiac valve disorders.
Cardiovascular problems are more common because of sedentary lifestyles, physical inactivity, and other habits such as smoking. The need for minimally-invasive procedures for cardiac abnormalities has consequently grown significantly over the world. A structural heart condition is a non-coronary heart problem that does not impact the heart's blood arteries. The majority of structural cardiac abnormalities are present at birth, but they can also develop later in life as a result of infection-related wear and tear.
Transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR) are two minimally-invasive procedures that have replaced open heart surgical procedures as a result of medical advancements. Transcatheter heart valve demand is rising as a result of a steady movement toward minimally-invasive procedures among patients who are becoming more aware of their therapeutic options. Furthermore, the development of new products and technological advancements will probably accelerate the growth of transcatheter heart valves.
- Edward Lifesciences got the CE mark for Edwards SAPIEN 3 in November 2019 to increase its use in the treatment of aortic stenosis patients who are at a lesser risk for open heart surgeries.
Patients who require full or partial valve replacement have a new and cutting-edge therapeutic option available to them in the form of biological valves, also known as tissue-engineered heart valves (TEHV). A fresh example of a live heart valve made of the host's tissues and cells is a tissue-engineered heart valve.
Demand for cardiac ablation technologies is growing in a highly favourable environment due to recent innovations such as D electro-anatomical mapping systems and robotic catheter navigation systems, as well as the widespread acceptance of catheter ablation as the first line of therapy.
Report Attributes |
Details |
|
Market Size (2023E) |
US$ 12.17 Billion |
|
Forecasted Market Value (2033F) |
US$ 36.06 Billion |
|
Global Market Growth Rate (2023-2033) |
11% CAGR |
|
China Market Growth Rate (2023-2033) |
10% CAGR |
|
Japan Market Growth Rate (2023-2033) |
10% CAGR |
|
Germany Market Growth Rate (2023-2033) |
8.5% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Why are Sales of Structural Heart Devices Increasing Rapidly?
“High Demand for Minimally-invasive Procedures”
Transcatheter valve replacement is a minimally-invasive treatment in which the damaged or old valve is left in situ and a new one is inserted. Patients with symptomatic aortic stenosis who are at low, intermediate, or high risk for routine valve replacement can undergo the procedure, which is similar to inserting a stent in the artery.
Furthermore, the transcatheter valve replacement procedure's main benefit is that it may be performed with tiny incisions, leaving all of the chest bones in situ. Patients who have not been given a chance to have a valve replacement procedure are also benefiting from this method of treatment.
Compared to conventional valve replacement, these procedures necessitate a shorter hospital stay for the patients. Furthermore, the treatment is advantageous to patients of all risk levels and provides a viable choice for those who might otherwise have few options for aortic valve surgery.
“Huge Investments in R&D Activities and Advancements in Structural Heart Devices”
The development of the market for structural heart devices is being shaped by interventional catheter technologies. The demand for structural heart devices is expanding as a result of hybrid treatments, healthcare reforms, and partnerships between surgeons, interventionalists, and cardiologists.
The catheter lab or hybrid operating room will emerge as a result of the development of hybrid procedures, which combine surgical and interventional techniques. These will be constructed employing a combination of contemporary technology, sterility, superior imaging system, and ventilation to support both processes. This will be a time- and money-saving strategy with multidisciplinary competence, decreasing healthcare expenses and driving the growth of the structural heart devices market.
Improved CT scan machines have a positive effect on catheter technologies in the market for structural cardiac devices. Cardiologists and surgeons can map out the complete coronary tree with a single CT scan due to non-invasive measurements.
Furthermore, it will allow for the placement of virtual stents and a visual representation of how it would affect flow. This gadget speeds up the process, saves money on labour, and increases sales of structural heart devices.
Complete integration of 3D rotational angiography into other imaging programs is now possible. Transcatheter procedures inside the body are better visualised as a result. A significant 3D integration will be a highly efficient corrective action for the management of chronic complete occlusions (CTO). With the use of contemporary 3D rotational angiography, the demand for structural heart devices is increasing quickly.
What Do Structural Heart Device Providers Need to Tackle?
“High Prices Associated With Heart-related Disorder Treatment & Devices”
Being an intrusive procedure, replacing a heart valve is associated with potential risks, which is a primary issue limiting the sales of structural heart medical devices. Replacement surgeries have several risks, including severe bleeding, arrhythmia, renal issues, stroke, cardiac arrest, infection, clotting, and others.
Although there are reduced risks and consequences associated with minimally-invasive procedures, the cost of the surgeries is still relatively high when compared to invasive surgical procedures. These challenges may, to some extent, have a serious effect on the patient population having surgical treatment.
However, the global demand for structural heart devices is being constrained by concerns such as strict governmental laws for product approvals and a lack of qualified specialists in some developing or poor nations.
Country-wise Analysis
Which Aspects are Supporting the Sales of Structural Heart Devices in the U.S.?
“Rising Prevalence of Cardiovascular Disorders”
The United States leads the North American market due to factors such as expanding healthcare spending, escalating research and development activities, and an increase in the prevalence of heart disorders. Another key driver boosting the sales of structural heart devices in the U.S. is the growing geriatric population in the country.
- According to data updated by Cedars-Sinai in January 2022, coronary artery bypass graft surgery (also known as coronary artery bypass, or bypass surgery), or CABG, is the most common type of heart surgery. In the United States, over 300,000 people undergo successful bypass surgery each year. Thus, the prevalence of cardiovascular diseases is increasing across the nation.
- Additionally, according to data from the Centers for Disease Control and Prevention (CDC) updated in July 2022, coronary heart disease is the most prevalent form of heart condition, affecting about 20.1 million individuals in the country who are 20 years of age and older.
- Also, according to the same source, a heart attack occurs every 40 seconds, and every year, nearly 805,000 Americans experience a heart attack.
Because of the significant prevalence of cardiovascular disorders, structural heart device demand is increasing in the American healthcare system.
How is Demand for Structural Heart Devices Progressing in European Region?
“Growing Rate of Senior Population and Advancements in Structural Heart Devices”
Some of the profitable marketplaces in the European region are Germany, the U.K., France & Italy.
- For instance, the "UK Factsheet January 2022" released by the "British Heart Foundation (BHF)" indicates that approximately 7.6 million people in the UK are affected by heart and circulation disorders.
- Additionally, according to the same source, the country's population of 3.6 million women and 4 million men had heart and circulatory disease diagnoses in 2021.
For patient survival, the high prevalence of heart and circulatory disease patients drives the need for further treatment procedures including angioplasty and cardiac operations. Thus, this is opening new opportunities in the structural heart devices market such as the introduction of advanced structural heart valves and annuloplasty rings.
Due to the country's growing senior population and improving healthcare infrastructure, the market in Germany is predicted to grow rapidly. Statistics from several studies show that more than 25,000 replacement procedures are performed annually in Germany. The clinical use of TAVR and TAVI implantations is likewise leading the way in Germany.
Sales of structural heart devices in Germany are predicted to rise at a CAGR of 8.5% from 2023 to 2033.
Furthermore, the country's availability of highly qualified multidisciplinary cardiac experts is assisting Germany's market growth and, in turn, the development of the European market.
Why is Asia Pacific the Fastest-Growing Market for Structural Heart Devices?
“Rapid Developments in Healthcare Infrastructure”
Asia Pacific is expected to be the fastest-emerging market for structural heart devices, with India, China, Japan, and South Korea being the top economies in the region.
Key growth factors include significant market participant investment and advancements in healthcare infrastructure. Due to improved life expectancy and low pricing, structural heart devices and techniques are anticipated to command the largest market share in terms of volume.
Because there is a greater prevalence of cardiovascular disease in developing nations, manufacturers of structural heart devices are looking into the untapped development potential in these nations. Longer life expectancy is ensured by these devices.
The healthcare systems of several Asian nations are rapidly developing. To better treat its population, respective governmental organisations are concentrating on developing their healthcare infrastructure. This aspect is directly boosting the demand for structural heart devices.
Demand for structural heart devices in China and Japan is expected to increase at a similar CAGR of 10%, respectively, during the next 10 years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Analysis
Why Do Patients Prefer Hospitals Over Other Facilities?
“Availability of Innovative Medical Devices”
Demand for structural heart devices from hospitals is primarily driven by the rise in hospital procedures, advantageous health reimbursement policies, and better government standards for the management of vulvar disorders.
The rapid rise is linked to people looking for effective treatments that shorten hospital visits and recovery times. Additionally, the widespread use of innovative medical technologies and heart repair devices in hospitals promotes sales growth.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Some of the key players in the structural heart devices market are Abbott Laboratories, Centerline Biomedical, Inc., Medtronic Inc., Boston Scientific Corporation, and more.
Leading companies are embracing novel strategies to increase their market share, including cutting-edge marketing tactics, technological breakthroughs, mergers, and acquisitions.
- Abbott Laboratories unveiled a novel, minimally-invasive vascular heart valve repair device in May 2022. New information was also provided by the company about Amplatzer Amulet and MitraClip, two essential items in its market-leading Abbott structural heart devices portfolio.
- For instance, Centerline Biomedical, Inc. finished the second animal study in a series on structural heart navigation in May 2022. The viability of using the company's augmented reality picture guidance technology to navigate structures in a beating heart was assessed by doctors from Cleveland Clinic's Heart, Vascular and Thoracic Institute.
- In 2022, Medtronic Inc. announced that it will purchase Affera, a company that develops therapies for cardiac arrhythmias. This acquisition is probably going to increase the company's portfolio of heart ablation procedures, allowing for the development of maps to identify arrhythmias. This will also increase the Medtronic structural heart device offerings.
Segments of Structural Heart Devices Industry Research
-
By Product :
- Heart Valve Devices
- Surgical Heart Valves
- Transcatheter Heart Valves
- Occluders & Delivery Systems
-
By Procedure:
- Replacement Procedures
- Repair Procedures
-
By Age Group :
- Pediatrics
- Adults
- Geriatrics
-
By Indication :
- Atrial Septal Defect (ASD)
- Ventricular Septal Defect (VSD)
- Patent Foramen Ovale (PFO)
- Aortic Valve Stenosis
-
By End User :
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Market Background 4.1. Macro-Economic Factors 4.1.1. Rise in Expenditure 4.1.2. Increased Per Capita Expenditure 4.2. Forecast Factors - Relevance & Impact 4.2.1. Product in Pipeline 4.2.2. Regulatory Scenario 4.2.3. Mergers and Acquisitions 4.2.4. Collaborative Agreements 4.2.5. Value Chain 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity Analysis 4.4. COVID19 Crisis Analysis 4.4.1. Current COVID19 Statistics and Probable Future Impact 4.4.2. Current GDP Projection and Probable Impact 4.4.3. Current Economic Projection as Compared to 2008 Economic analysis 4.4.4. COVID19 and Impact Analysis 4.4.4.1. Revenue By Product 4.4.4.2. Revenue By Age Group 4.4.4.3. Revenue By Procedure 4.4.4.4. Revenue By Indication 4.4.4.5. Revenue By End User 4.4.4.6. Revenue By Country 4.4.5. 2020 Market Scenario 4.4.6. Quarter by Quarter Forecast 4.4.7. Projected Recovery Quarter 4.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact 5. Market Context 5.1. Adoption and Usage Analysis 5.2. Market Evolution 5.3. Product Vs Age Group Matrix 5.4. Regulatory Scenario 5.5. Parent Market Analysis 5.6. Key Promotional Strategies by Market Players 6. Global Market - Pricing Analysis 6.1. Regional Pricing Analysis By Product 6.2. Pricing Break-up 6.2.1. Manufacturer Level Pricing 6.2.2. Distributor Level Pricing 6.3. Global Average Pricing Analysis Benchmark 7. Global Market Value Analysis 2018-2022 and Forecast, 2023-2033 7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Product 8.1. Introduction / Key Findings 8.2. Historical Market Indication (US$ Mn) Analysis By Product, 2018-2022 8.3. Current and Future Market Indication (US$ Mn) Analysis and Forecast By Product, 2023-2033 8.3.1. Heart Valve Devices 8.3.2. Surgical Heart Valves 8.3.3. Transcatheter Heart Valves 8.3.4. Occluders & Delivery Systems 8.4. Market Attractiveness Analysis By Product 9. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Procedure 9.1. Introduction / Key Findings Procedure Indication, 2018-2022 9.2. Current and Future Market Indication (US$ Mn) Analysis and Forecast By Procedure, 2023-2033 9.2.1. Replacement Procedures 9.2.2. Repair Procedures 9.3. Market Attractiveness Analysis By Procedure 10. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Age Group 10.1. Introduction / Key Findings Age Group Indication, 2018-2022 10.2. Current and Future Market Indication (US$ Mn) Analysis and Forecast By Age Group, 2023-2033 10.2.1. Pediatrics 10.2.2. Adults 10.2.3. Geriatrics 10.3. Market Attractiveness Analysis By Age Group 11. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Indication 11.1. Introduction / Key Findings Indication, 2018-2022 11.2. Current and Future Market Indication (US$ Mn) Analysis and Forecast By Indication, 2023-2033 11.2.1. Atrial Septal Defect (ASD) 11.2.2. Ventricular Septal Defect (VSD) 11.2.3. Patent Foramen Ovale (PFO) 11.2.4. Aortic Valve Stenosis 11.3. Market Attractiveness Analysis By Indication 12. Global Market Analysis 2018-2022 and Forecast 2023-2033, by End User 12.1. Introduction / Key Findings 12.2. Historical Market Indication (US$ Mn) Analysis By End User, 2018-2022 12.3. Current and Future Market Indication (US$ Mn) Analysis and Forecast By End User, 2023-2033 12.3.1. Hospitals 12.3.2. Ambulatory Surgical Centers 12.3.3. Cardiac Centers 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2018-2022 and Forecast 2023-2033, by Region 13.1. Introduction 13.2. Historical Market Indication (US$ Mn) Analysis By Region, 2018-2022 13.3. Current Market Indication (US$ Mn) Analysis and Forecast By Region, 2023-2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. East Asia 13.3.5. South Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2018-2022 and Forecast 2023-2033 14.1. Introduction 14.2. Historical Market Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 14.3. Market Indication (US$ Mn) Forecast By Market Taxonomy, 2023-2033 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Procedure 14.3.4. By Age Group 14.3.5. By Indication 14.3.6. By End User 14.4. Market Attractiveness Analysis 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018-2022 and Forecast 2023-2033 15.1. Introduction 15.2. Historical Market Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 15.3. Market Indication (US$ Mn) Forecast By Market Taxonomy, 2023-2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Rest of Europe 15.3.2. By Product 15.3.3. By Procedure 15.3.4. By Age Group 15.3.5. By Indication 15.3.6. By End User 15.4. Market Attractiveness Analysis 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. Middle East and Africa Market Analysis 2018-2022 and Forecast 2023-2033 16.1. Introduction 16.2. Historical Market Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 16.3. Market Indication (US$ Mn) Forecast By Market Taxonomy, 2023-2033 16.3.1. By Country 16.3.1.1. GCC Countries 16.3.1.2. South Africa 16.3.1.3. Rest of Middle East and Africa 16.3.2. By Product 16.3.3. By Procedure 16.3.4. By Age Group 16.3.5. By Indication 16.3.6. By End User 16.4. Market Attractiveness Analysis 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. Rest of the World Market Analysis 2018-2022 and Forecast 2023-2033 17.1. Introduction 17.2. Historical Market Indication (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022 17.3. Market Indication (US$ Mn) Forecast By Market Taxonomy, 2023-2033 17.3.1. By Product 17.3.2. By Procedure 17.3.3. By Age Group 17.3.4. By Indication 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. Key and Emerging Countries Market Analysis 2018-2022 and Forecast 2023-2033 18.1. Introduction 18.1.1. Market Value Proportion Analysis, By Key Countries 18.1.2. Global Vs. Country Growth Comparison 18.2. U.S. Market Analysis 18.2.1. By Product 18.2.2. By Procedure 18.2.3. By Age Group 18.2.4. By Indication 18.2.5. By End User 18.3. Canada Market Analysis 18.3.1. By Product 18.3.2. By Procedure 18.3.3. By Age Group 18.3.4. By Indication 18.3.5. By End User 18.4. U.K. Market Analysis 18.4.1. By Product 18.4.2. By Procedure 18.4.3. By Age Group 18.4.4. By Indication 18.4.5. By End User 18.5. Germany Market Analysis 18.5.1. By Product 18.5.2. By Procedure 18.5.3. By Age Group 18.5.4. By Indication 18.5.5. By End User 18.6. France Market Analysis 18.6.1. By Product 18.6.2. By Procedure 18.6.3. By Age Group 18.6.4. By Indication 18.6.5. By End User 18.7. Italy Market Analysis 18.7.1. By Product 18.7.2. By Procedure 18.7.3. By Age Group 18.7.4. By Indication 18.7.5. By End User 18.8. Spain Market Analysis 18.8.1. By Product 18.8.2. By Procedure 18.8.3. By Age Group 18.8.4. By Indication 18.8.5. By End User 18.8.6. By End User 18.9. GCC Countries Market Analysis 18.9.1. By Product 18.9.2. By Procedure 18.9.3. By Age Group 18.9.4. By Indication 18.9.5. By End User 18.10. South Africa Market Analysis 18.10.1. By Product 18.10.2. By Procedure 18.10.3. By Age Group 18.10.4. By Indication 18.10.5. By End User 19. Market Structure Analysis 19.1. Market Analysis by Tier of Companies 19.2. Market Concentration 19.3. Market Share Analysis of Top Players 19.4. Market Presence Analysis 19.4.1. By Regional footprint of Players 19.4.2. Product foot print by Players 19.4.3. Channel Foot Print by Players 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. Abbott Laboratories, Inc. 20.3.1.1. Overview 20.3.1.2. Product Portfolio 20.3.1.3. Analyst Commentary 20.3.1.4. Key Financials 20.3.1.5. Recent Developments 20.3.1.6. Sales Footprint 20.3.1.7. Strategy Overview 20.3.1.7.1. Marketing Strategy 20.3.1.7.2. Product Strategy 20.3.1.7.3. Channel Strategy 20.3.2. Boston Scientific Corporation 20.3.2.1. Overview 20.3.2.2. Product Portfolio 20.3.2.3. Analyst Commentary 20.3.2.4. Key Financials 20.3.2.5. Recent Developments 20.3.2.6. Sales Footprint 20.3.2.7. Strategy Overview 20.3.2.7.1. Marketing Strategy 20.3.2.7.2. Product Strategy 20.3.2.7.3. Channel Strategy 20.3.3. Braile Biomedica 20.3.3.1. Overview 20.3.3.2. Product Portfolio 20.3.3.3. Analyst Commentary 20.3.3.4. Key Financials 20.3.3.5. Recent Developments 20.3.3.6. Sales Footprint 20.3.3.7. Strategy Overview 20.3.3.7.1. Marketing Strategy 20.3.3.7.2. Product Strategy 20.3.3.7.3. Channel Strategy 20.3.4. CryoLife, Inc. 20.3.4.1. Overview 20.3.4.2. Product Portfolio 20.3.4.3. Analyst Commentary 20.3.4.4. Key Financials 20.3.4.5. Recent Developments 20.3.4.6. Sales Footprint 20.3.4.7. Strategy Overview 20.3.4.7.1. Marketing Strategy 20.3.4.7.2. Product Strategy 20.3.4.7.3. Channel Strategy 20.3.5. Edwards Lifesciences Corporation 20.3.5.1. Overview 20.3.5.2. Product Portfolio 20.3.5.3. Analyst Commentary 20.3.5.4. Key Financials 20.3.5.5. Recent Developments 20.3.5.6. Sales Footprint 20.3.5.7. Strategy Overview 20.3.5.7.1. Marketing Strategy 20.3.5.7.2. Product Strategy 20.3.5.7.3. Channel Strategy 20.3.6. Lepu Medical Technology (Beijing) Co., Ltd. 20.3.6.1. Overview 20.3.6.2. Product Portfolio 20.3.6.3. Analyst Commentary 20.3.6.4. Key Financials 20.3.6.5. Recent Developments 20.3.6.6. Sales Footprint 20.3.6.7. Strategy Overview 20.3.6.7.1. Marketing Strategy 20.3.6.7.2. Product Strategy 20.3.6.7.3. Channel Strategy 20.3.7. LivaNova PLC 20.3.7.1. Overview 20.3.7.2. Product Portfolio 20.3.7.3. Analyst Commentary 20.3.7.4. Key Financials 20.3.7.5. Recent Developments 20.3.7.6. Sales Footprint 20.3.7.7. Strategy Overview 20.3.7.7.1. Marketing Strategy 20.3.7.7.2. Product Strategy 20.3.7.7.3. Channel Strategy 20.3.8. Medtronic PLC 20.3.8.1. Overview 20.3.8.2. Product Portfolio 20.3.8.3. Analyst Commentary 20.3.8.4. Key Financials 20.3.8.5. Recent Developments 20.3.8.6. Sales Footprint 20.3.8.7. Strategy Overview 20.3.8.7.1. Marketing Strategy 20.3.8.7.2. Product Strategy 20.3.8.7.3. Channel Strategy 20.3.9. Micro Interventional Devices, Inc. 20.3.9.1. Overview 20.3.9.2. Product Portfolio 20.3.9.3. Analyst Commentary 20.3.9.4. Key Financials 20.3.9.5. Recent Developments 20.3.9.6. Sales Footprint 20.3.9.7. Strategy Overview 20.3.9.7.1. Marketing Strategy 20.3.9.7.2. Product Strategy 20.3.9.7.3. Channel Strategy 20.3.10. TTK Healthcare Ltd. 20.3.10.1. Overview 20.3.10.2. Product Portfolio 20.3.10.3. Analyst Commentary 20.3.10.4. Key Financials 20.3.10.5. Recent Developments 20.3.10.6. Sales Footprint 20.3.10.7. Strategy Overview 20.3.10.7.1. Marketing Strategy 20.3.10.7.2. Product Strategy 20.3.10.7.3. Channel Strategy 21. Assumptions and Acronyms Used 22. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product
Table 02: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Procedure
Table 03: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Age Group
Table 04: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Indication
Table 05: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 06: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Indication Age Group
Table 07: Global Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Region
Table 08: North America Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 09: North America Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product
Table 10: North America Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Age Group
Table 11: North America Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Procedure
Table 12: North America Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Indication
Table 13: North America Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 14: Europe Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 15: Europe Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product
Table 16: Europe Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Age Group
Table 17: Europe Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Procedure
Table 18: Europe Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Indication
Table 19: Europe Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 20: Middle East and Africa Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Country
Table 21: Middle East and Africa Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product
Table 22: Middle East and Africa Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Age Group
Table 23: Middle East and Africa Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Procedure
Table 24: Middle East and Africa Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Indication
Table 25: Middle East and Africa Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
Table 26: Rest of the World Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Product
Table 27: Rest of the World Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Age Group
Table 28: Rest of the World Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Procedure
Table 29: Rest of the World Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By Indication
Table 30: Rest of the World Market Indication (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033, By End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033
Figure 02: Global Market Absolute $ Opportunity, 2023-2033
Figure 03: Global Market Share Analysis (%), By Product, 2023 & 2033
Figure 04: Global Market Y-o-Y Analysis (%), By Product, 2023-2033
Figure 05: Global Market Attractiveness Analysis By Product, 2023-2033
Figure 06: Global Market Share Analysis (%), By Procedure, 2023 & 2033
Figure 07: Global Market Y-o-Y Analysis (%), By Procedure, 2023-2033
Figure 08: Global Market Attractiveness Analysis By Procedure, 2023-2033
Figure 09: Global Market Share Analysis (%), By Age Group, 2023 & 2033
Figure 10: Global Market Y-o-Y Analysis (%), By Age Group, 2023-2033
Figure 11: Global Market Attractiveness Analysis By Age Group, 2023-2033
Figure 12: Global Market Share Analysis (%), By Indication, 2023 & 2033
Figure 13: Global Market Y-o-Y Analysis (%), By Indication, 2023-2033
Figure 14: Global Market Attractiveness Analysis By Indication, 2023-2033
Figure 15: Global Market Share Analysis (%), By End User, 2023 & 2033
Figure 16: Global Market Y-o-Y Analysis (%), By End User , 2023-2033
Figure 17: Global Market Attractiveness Analysis, By End User, 2023-2033
Figure 18: Global Market Share Analysis (%), By Indication Age Group, 2023 & 2033
Figure 19: Global Market Y-o-Y Analysis (%), By Indication Age Group, 2023-2033
Figure 20: Global Market Attractiveness Analysis By Indication Age Group, 2023-2033
Figure 21: Global Market Share Analysis (%), By Region, 2023 & 2033
Figure 22: Global Market Y-o-Y Analysis (%), By Region, 2023-2033
Figure 23: Global Market Attractiveness Analysis, By Region, 2023-2033
Figure 24: North America Market Value Share, By Product, 2023 (E)
Figure 25: North America Market Value Share, By Age Groups 2023 (E)
Figure 26: North America Market Value Share, By Procedure, 2023 (E)
Figure 27: North America Market Value Share, By Indication, 2023 (E)
Figure 28: North America Market Value Share, By End User, 2023 (E)
Figure 29: North America Market Value Share, By Country, 2023 (E)
Figure 30: North America Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033
Figure 31: North America Market Attractiveness Analysis By Product, 2023-2033
Figure 32: North America Market Attractiveness Analysis By Age Group, 2023-2033
Figure 33: North America Market Attractiveness Analysis By Procedure, 2023-2033
Figure 34: North America Market Attractiveness Analysis By Indication, 2023-2033
Figure 35: North America Market Attractiveness Analysis By End User, 2023-2033
Figure 36: North America Market Attractiveness Analysis By Country, 2023-2033
Figure 37: Europe Market Value Share, By Product, 2023 (E)
Figure 38: Europe Market Value Share, By Age Groups 2023 (E)
Figure 39: Europe Market Value Share, By Procedure, 2023 (E)
Figure 40: Europe Market Value Share, By Indication, 2023 (E)
Figure 41: Europe Market Value Share, By End User, 2023 (E)
Figure 42: Europe Market Value Share, By Country, 2023 (E)
Figure 43: Europe Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033
Figure 44: Europe Market Attractiveness Analysis By Product, 2023-2033
Figure 45: Europe Market Attractiveness Analysis By Age Group, 2023-2033
Figure 46: Europe Market Attractiveness Analysis By Procedure, 2023-2033
Figure 47: Europe Market Attractiveness Analysis By Indication, 2023-2033
Figure 48: Europe Market Attractiveness Analysis By Procedure, 2023-2033
Figure 49: Europe Market Attractiveness Analysis By Country, 2023-2033
Figure 50: Middle East and Africa Market Value Share, By Product, 2023 (E)
Figure 51: Middle East and Africa Market Value Share, By Age Group, 2023 (E)
Figure 52: Middle East and Africa Market Value Share, By Procedure, 2023 (E)
Figure 53: Middle East and Africa Market Value Share, By Indication, 2023 (E)
Figure 54: Middle East and Africa Market Value Share, By End User, 2023 (E)
Figure 55: Middle East and Africa Market Value Share, By Country, 2023 (E)
Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033
Figure 57: Middle East and Africa Market Attractiveness Analysis By Product, 2023-2033
Figure 58: Middle East and Africa Market Attractiveness Analysis By Age Group, 2023-2033
Figure 59: Middle East and Africa Market Attractiveness Analysis By Procedure, 2023-2033
Figure 60: Middle East and Africa Market Attractiveness Analysis By Indication, 2023-2033
Figure 61: Middle East and Africa Market Attractiveness Analysis By End User, 2023-2033
Figure 62: Middle East and Africa Market Attractiveness Analysis By Country, 2023-2033
Figure 63: Rest of the World Market Value Share, By Product, 2023 (E)
Figure 64: Rest of the World Market Value Share, By Age Groups 2023 (E)
Figure 65: Rest of the World Market Value Share, By Procedure, 2023 (E)
Figure 66: Rest of the World Market Value Share, By Indication, 2023 (E)
Figure 67: Rest of the World Market Value Share, By End User, 2023 (E)
Figure 68: Rest of the World Market Value (US$ Mn) Analysis 2018-2022 and Forecast 2023-2033
Figure 69: Rest of the World Market Attractiveness Analysis By Product, 2023-2033
Figure 70: Rest of the World Market Attractiveness Analysis By Age Group, 2023-2033
Figure 71: Rest of the World Market Attractiveness Analysis By Procedure, 2023-2033
Figure 72: Rest of the World Market Attractiveness Analysis By Indication, 2023-2033
Figure 73: Rest of the World Market Attractiveness Analysis By End User, 2023-2033
Figure 74: U.S. Market Value Share, By Product, 2023 & 2033
Figure 75: U.S. Market Value Share, By Age Group, 2023 & 2033
Figure 76: U.S. Market Value Share, By Procedure, 2020 &2030
Figure 77: U.S. Market Value Share, By Indication Age Group, 2023 & 2033
Figure 78: U.S. Market Value Share, By End User, 2023 & 2033
Figure 79: U.S. Market Value Analysis (US$ Mn), 2023 & 2033
Figure 80: Canada Market Value Share, By Product, 2023 & 2033
Figure 81: Canada Market Value Share, By Age Group, 2023 & 2033
Figure 82: Canada Market Value Share, By Procedure, 2023 & 2033
Figure 83: Canada Market Value Share, By Indication Age Group, 2023 & 2033
Figure 84: Canada Market Value Share, By End User, 2023 & 2033
Figure 85: Canada Market Value Analysis (US$ Mn), 2023 & 2033
Figure 86: U.K. Market Value Share, By Product, 2023 & 2033
Figure 87: U.K. Market Value Share, By Age Group, 2023 & 2033
Figure 88: U.K. Market Value Share, By Procedure, 2023 & 2033
Figure 89: U.K. Market Value Share, By Indication Age Group, 2023 & 2033
Figure 90: U.K. Market Value Share, By End User, 2023 & 2033
Figure 91: U.K. Market Value Analysis (US$ Mn), 2023 & 2033
Figure 92: Germany Market Value Share, By Product, 2023 & 2033
Figure 93: Germany Market Value Share, By Age Group, 2023 & 2033
Figure 94: Germany Market Value Share, By Procedure, 2023 & 2033
Figure 95: Germany Market Value Share, By Indication Age Group, 2023 & 2033
Figure 96: Germany Market Value Share, By End User, 2023 & 2033
Figure 97: Germany Market Value Analysis (US$ Mn), 2023 & 2033
Figure 98: France Market Value Share, By Product, 2023 & 2033
Figure 99: France Market Value Share, By Age Group, 2023 & 2033
Figure 100: France Market Value Share, By Procedure, 2023 & 2033
Figure 101: France. Market Value Share, By Indication Age Group, 2023 & 2033
Figure 102: France Market Value Share, By End User, 2023 & 2033
Figure 103: France Market Value Analysis (US$ Mn), 2023 & 2033
Figure 104: Italy Market Value Share, By Product, 2023 & 2033
Figure 105: Italy Market Value Share, By Age Group, 2023 & 2033
Figure 106: Italy Market Value Share, By Procedure, 2023 & 2033
Figure 107: Italy Market Value Share, By Indication Age Group, 2023 & 2033
Figure 108: Italy Market Value Share, By End User, 2023 & 2033
Figure 109: Italy Market Value Analysis (US$ Mn), 2023 & 2033
Figure 110: Spain Market Value Share, By Product, 2023 & 2033
Figure 111: Spain Market Value Share, By Age Group, 2023 & 2033
Figure 112: Spain Market Value Share, By Procedure, 2023 & 2033
Figure 113: Spain Market Value Share, By Indication Age Group, 2023 & 2033
Figure 114: Spain Market Value Share, By End User, 2023 & 2033
Figure 115: Spain Market Value Analysis (US$ Mn), 2023 & 2033
Figure 116: GCC Countries. Market Value Share, By Product, 2023 & 2033
Figure 117: GCC Countries Market Value Share, By Age Group, 2023 & 2033
Figure 118: GCC Countries Market Value Share, By Procedure, 2023 & 2033
Figure 119: GCC Countries Market Value Share, By Indication, 2023 & 2033
Figure 120: GCC Countries Market Value Share, By End User, 2023 & 2033
Figure 121: GCC Countries Market Value Analysis (US$ Mn), 2023 & 2033
Figure 122: South Africa Market Value Share, By Product, 2023 & 2033
Figure 123: South Africa Market Value Share, By Age Group, 2023 & 2033
Figure 124: South Africa Market Value Share, By Procedure, 2023 & 2033
Figure 125: South Africa Market Value Share, By Indication Age Group, 2023 & 2033
Figure 126: South Africa Market Value Share, By End User, 2023 & 2033
Figure 127: South Africa Market Value Analysis (US$ Mn), 2023 & 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the market value of structural heart devices?
Worldwide structural heart device sales are valued at US$ 12.17 billion in 2023.
What is the estimated CAGR for the structural heart devices market?
Global demand for structural heart devices is predicted to increase at a CAGR of 11% through 2033.
What is the projected value of the market for 2033?
The market for structural heart devices is likely to reach US$ 36.06 billion by 2033.
Which is the dominating regional market?
North America holds a significant position in the global structural heart devices market.
Who are the top 3 market players?
Leading manufacturers of structural heart devices are Abbott Laboratories, Centerline Biomedical, Inc., Medtronic Inc., and Boston Scientific Corporation.
Structural Heart Devices Market